Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

NBIX.US Logo

NBIX.US - Current Price

$132.10

Company Information

▼
Company Name
Neurocrine Biosciences Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US64125C1099
CIK: 0000914475
CUSIP: 64125C109
Currency: USD
Full Time Employees: 1,800
Phone: 858 617 7600
Website: https://www.neurocrine.com
Fiscal Year End: December
IPO Date: May 23, 1996
Description:

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Address:

12780 El Camino Real, San Diego, CA, United States, 92130

Directors & Officers

▼
Name Title Year Born
Mr. Kyle W. Gano Ph.D. CEO & Director 1973
Mr. Matthew C. Abernethy CPA Chief Financial Officer 1980
Dr. Jude Onyia Ph.D. Chief Scientific Officer 1965
Mr. Eric S. Benevich Chief Commercial Officer 1965
Dr. Eiry Wyn Roberts M.D. Strategic Advisor 1964
Dr. Wylie W. Vale Ph.D. Co-Founder 1942
Dr. Lawrence Steinman BA, M.D., Ph.D. Co-Founder of Neurocrine 1948
Mr. Lewis Choi Chief Information Officer NA
Jane Sorensen Head of Investor Relations NA
Mr. Darin M. Lippoldt Esq. Chief Legal Officer & Corporate Secretary 1966

Shares Statistics

▼
Shares Outstanding: 99.71M
Shares Float: 98.53M
% Insiders: 102.00%
% Institutions: 10,123.30%
Short % Float: 5.26%

Valuation Metrics

▼
Enterprise Value: $12.85B
Trailing P/E: 31.66
Forward P/E: 19.01

Financial Highlights

▼
Market Cap: $13.23B
EBITDA: $570.00M
P/E Ratio: $31.66
PEG Ratio: $0.27
Book Value: $30.13
Earnings/Share: $4.19
Profit Margin: 15.95%
Operating Margin: 30.10%
ROA (TTM): 8.66%
ROE (TTM): 14.96%
Revenue (TTM): $2.68B
Revenue/Share (TTM): $26.98
Earnings Growth (YOY): 64.50%
Revenue Growth (YOY): 27.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 1.81 N/A -10,000.00%
Sep 30, 2025 2.17 2.09 N/A 382.78%
Jun 30, 2025 1.65 1.50 N/A 1,000.00%
Mar 31, 2025 0.70 1.09 N/A -3,577.98%
Dec 31, 2024 1.69 1.93 N/A -1,243.52%
Sep 30, 2024 1.81 1.82 N/A -54.95%
Jun 30, 2024 0.63 1.05 N/A -4,000.00%
Mar 31, 2024 0.42 1.01 N/A -5,841.58%
Dec 31, 2023 1.44 1.15 N/A 2,521.74%
Sep 30, 2023 0.82 0.97 N/A -1,546.39%
Jun 30, 2023 0.95 0.78 N/A 2,179.49%
Mar 31, 2023 -0.79 0.13 N/A -70,769.23%
Dec 31, 2022 0.88 1.16 N/A -2,413.79%
Sep 30, 2022 0.69 0.79 N/A -1,265.82%
Jun 30, 2022 -0.18 0.60 N/A -13,000.00%
Mar 31, 2022 0.14 0.35 N/A -6,000.00%
Dec 31, 2021 -0.08 0.52 N/A -11,538.46%
Sep 30, 2021 0.64 0.60 N/A 666.67%
Jun 30, 2021 0.43 0.48 N/A -1,041.67%
Mar 31, 2021 0.33 0.51 N/A -3,529.41%
Dec 31, 2020 0.72 0.54 N/A 3,333.33%
Sep 30, 2020 -0.62 0.22 N/A -38,181.82%
Jun 30, 2020 0.81 0.73 N/A 1,095.89%
Mar 31, 2020 0.39 0.54 N/A -2,777.78%
Dec 31, 2019 0.35 0.75 N/A -5,333.33%
Sep 30, 2019 0.56 0.64 N/A -1,250.00%
Jun 30, 2019 0.54 0.11 N/A 39,090.91%
Mar 31, 2019 -1.12 -0.92 N/A -2,173.91%
Dec 31, 2018 0.19 0.18 N/A 555.56%
Sep 30, 2018 0.52 0.46 N/A 1,304.35%
Jun 30, 2018 -0.07 -0.17 N/A 5,882.35%
Mar 31, 2018 -0.47 -0.30 N/A -5,666.67%
Dec 31, 2017 0.07 0.18 N/A -6,111.11%
Sep 30, 2017 -0.13 -0.48 N/A 7,291.67%
Jun 30, 2017 -0.68 -0.66 N/A -303.03%
Mar 31, 2017 -0.90 -0.74 N/A -2,162.16%
Dec 31, 2016 -0.51 -0.56 N/A 892.86%
Sep 30, 2016 -0.43 -0.57 N/A 2,456.14%
Jun 30, 2016 -0.46 -0.49 N/A 612.24%
Mar 31, 2016 -0.22 -0.28 N/A 2,142.86%
Dec 31, 2015 -0.34 -0.32 N/A -625.00%
Sep 30, 2015 -0.40 -0.25 N/A -6,000.00%
Jun 30, 2015 -0.28 -0.29 N/A 344.83%
Mar 31, 2015 -0.01 -0.30 N/A 9,666.67%
Dec 31, 2014 -0.26 -0.24 N/A -833.33%
Sep 30, 2014 -0.21 -0.21 N/A 0.00%
Jun 30, 2014 -0.18 -0.18 N/A 0.00%
Mar 31, 2014 -0.17 -0.19 N/A 1,052.63%
Dec 31, 2013 -0.16 -0.17 N/A 588.24%
Sep 30, 2013 -0.17 -0.20 N/A 1,500.00%
Jun 30, 2013 -0.18 -0.19 N/A 526.32%
Mar 31, 2013 -0.18 -0.18 N/A 0.00%
Dec 31, 2012 0.14 -0.08 N/A 27,500.00%
Sep 30, 2012 -0.05 -0.05 N/A 0.00%
Jun 30, 2012 -0.01 -0.03 N/A 6,666.67%
Mar 31, 2012 -0.01 -0.01 N/A 0.00%
Dec 31, 2011 0.02 0.02 N/A 0.00%
Sep 30, 2011 0.56 0.19 N/A 19,473.68%
Jun 30, 2011 0.04 0.06 N/A -3,333.33%
Mar 31, 2011 0.05 0.05 N/A 0.00%
Dec 31, 2010 0.04 0.04 N/A 0.00%
Sep 30, 2010 0.06 0.05 N/A 2,000.00%
Jun 30, 2010 -0.09 -0.17 N/A 4,705.88%
Mar 31, 2010 -0.19 -0.24 N/A 2,083.33%
Dec 31, 2009 -0.20 -0.27 N/A 2,592.59%
Sep 30, 2009 -0.21 -0.35 N/A 4,000.00%
Jun 30, 2009 -0.39 -0.40 N/A 250.00%
Mar 31, 2009 -0.51 -0.39 N/A -3,076.92%
Dec 31, 2008 -0.75 -0.50 N/A -5,000.00%
Sep 30, 2008 -0.46 -0.51 N/A 980.39%
Jun 30, 2008 -0.55 -0.52 N/A -576.92%
Mar 31, 2008 -0.55 -0.55 N/A 0.00%
Dec 31, 2007 -0.89 -0.85 N/A -470.59%
Sep 30, 2007 -0.72 -0.78 N/A 769.23%
Jun 30, 2007 -0.69 -0.73 N/A 547.95%
Mar 31, 2007 -0.68 -0.66 N/A -303.03%
Dec 31, 2006 -0.39 -0.76 N/A 4,868.42%
Sep 30, 2006 -1.03 -0.91 N/A -1,318.68%
Jun 30, 2006 -0.73 -0.72 N/A -138.89%
Mar 31, 2006 -0.69 -0.63 N/A -952.38%
Dec 31, 2005 -0.65 -0.70 N/A 714.29%
Sep 30, 2005 0.68 0.48 N/A 4,166.67%
Jun 30, 2005 -0.15 -0.24 N/A 3,750.00%
Mar 31, 2005 -0.51 -0.64 N/A 2,031.25%
Dec 31, 2004 -0.57 -0.35 N/A -6,285.71%
Sep 30, 2004 -0.05 -0.39 N/A 8,717.95%
Jun 30, 2004 -0.31 -0.27 N/A -1,481.48%
Mar 31, 2004 -0.35 -0.36 N/A 277.78%
Dec 31, 2003 0.09 -0.14 N/A 16,428.57%
Sep 30, 2003 -0.31 -0.36 N/A 1,388.89%
Jun 30, 2003 -0.33 -0.38 N/A 1,315.79%
Mar 31, 2003 -0.43 -0.38 N/A -1,315.79%
Dec 31, 2002 -1.27 -0.85 N/A -4,941.18%
Sep 30, 2002 -0.66 -0.81 N/A 1,851.85%
Jun 30, 2002 -0.65 -0.68 N/A 441.18%
Mar 31, 2002 -0.52 -0.66 N/A 2,121.21%
Dec 31, 2001 -0.53 -0.50 N/A -600.00%
Sep 30, 2001 0.09 -0.30 N/A 13,000.00%
Jun 30, 2001 -0.52 -0.62 N/A 1,612.90%
Mar 31, 2001 -0.45 -0.56 N/A 1,964.29%
Dec 31, 2000 -0.29 -0.41 N/A 2,926.83%
Sep 30, 2000 -0.37 -0.13 N/A -18,461.54%
Jun 30, 2000 -0.24 -0.17 N/A -4,117.65%
Mar 31, 2000 -0.28 -0.37 N/A 2,432.43%
Dec 31, 1999 -0.19 -0.25 N/A 2,400.00%
Sep 30, 1999 -0.23 -0.23 N/A 0.00%
Jun 30, 1999 -0.24 -0.22 N/A -909.09%
Mar 31, 1999 -0.22 -0.09 N/A -14,444.44%
Dec 31, 1998 -0.18 0.00 N/A N/A
Sep 30, 1998 -0.22 -0.19 N/A -1,578.95%
Jun 30, 1998 -0.14 -0.17 N/A 1,764.71%
Mar 31, 1998 -0.07 -0.04 N/A -7,500.00%
Dec 31, 1997 0.00 -0.01 N/A 10,000.00%
Sep 30, 1997 0.06 0.05 N/A 2,000.00%
Jun 30, 1997 0.01 -0.02 N/A 15,000.00%
Mar 31, 1997 0.23 0.12 N/A 9,166.67%
Dec 31, 1996 0.24 0.21 N/A 1,428.57%
Sep 30, 1996 -0.02 0.03 N/A -16,666.67%
Jun 30, 1996 0.11 0.04 N/A 17,500.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $233.00M $N/A $3.72B $1.13B $2.59B
2023-12-31 $251.10M $N/A $3.25B $1.02B $2.23B
2022-12-31 $262.90M $N/A $2.37B $660.90M $1.71B
2021-12-31 $340.80M $N/A $2.07B $698.50M $1.37B
2020-12-31 $187.10M $N/A $1.73B $608.50M $1.13B
2019-12-31 $112.28M $N/A $1.31B $669.10M $636.90M
2018-12-31 $141.71M $N/A $993.15M $512.39M $480.77M
2017-12-31 $254.71M $N/A $817.59M $445.45M $372.14M
2016-12-31 $83.27M $N/A $365.09M $50.21M $314.88M
2015-12-31 $74.20M $N/A $474.79M $50.33M $424.45M
2014-12-31 $31.01M $N/A $243.03M $34.33M $208.70M
2013-12-31 $44.79M $N/A $154.68M $34.27M $120.41M
2012-12-31 $63.75M $N/A $195.98M $41.61M $154.37M
2011-12-31 $50.11M $N/A $138.37M $78.29M $60.08M
2010-12-31 $54.05M $N/A $144.42M $125.08M $19.35M
2009-12-31 $37.33M $N/A $70.82M $66.86M $3.95M
2008-12-31 $68.47M $N/A $118.18M $81.41M $36.77M
2007-12-31 $99.66M $N/A $276.65M $157.96M $118.70M
2006-12-31 $80.98M $N/A $389.68M $74.96M $314.72M
2005-12-31 $49.95M $N/A $483.12M $93.02M $390.10M
2004-12-31 $61.03M $N/A $519.22M $125.39M $393.83M
2003-12-31 $105.85M $N/A $554.96M $163.84M $391.12M
2002-12-31 $44.31M $N/A $266.54M $42.29M $224.25M
2001-12-31 $163.89M $N/A $346.35M $35.96M $310.39M
2000-12-31 $21.08M $N/A $185.96M $22.75M $163.21M
1999-12-31 $21.30M $N/A $109.20M $12.80M $96.40M
1998-12-31 $11.70M $N/A $80.50M $8.50M $72.00M
1997-12-31 $15.80M $N/A $91.90M $8.70M $83.20M
1996-12-31 $11.30M $N/A $78.00M $5.20M $72.80M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 07, 2025 N/A N/A N/A N/A N/A N/A
Jul 10, 2025 N/A N/A N/A N/A N/A N/A
Jul 09, 2025 N/A N/A N/A N/A N/A N/A
Jul 02, 2025 N/A N/A N/A N/A N/A N/A
Jun 17, 2025 N/A N/A N/A N/A N/A N/A
Jun 11, 2025 N/A N/A N/A N/A N/A N/A
May 27, 2025 N/A N/A N/A N/A N/A N/A
May 05, 2025 N/A N/A N/A N/A N/A N/A
Feb 13, 2025 N/A N/A N/A N/A N/A N/A
Feb 13, 2025 N/A N/A N/A N/A N/A N/A
Feb 13, 2025 N/A N/A N/A N/A N/A N/A
Feb 10, 2025 N/A N/A N/A N/A N/A N/A
Feb 10, 2025 N/A N/A N/A N/A N/A N/A
Feb 10, 2025 N/A N/A N/A N/A N/A N/A
Feb 03, 2025 N/A N/A N/A N/A N/A N/A
Jan 31, 2025 N/A N/A N/A N/A N/A N/A
Jan 31, 2025 N/A N/A N/A N/A N/A N/A
Jan 31, 2025 N/A N/A N/A N/A N/A N/A
Jan 31, 2025 N/A N/A N/A N/A N/A N/A
Jan 27, 2025 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist